These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 52004)

  • 21. IgA deficiency, epilepsy, and hydantoin medication.
    Fontana A; Grob PJ; Sauter R; Joller H
    Lancet; 1976 Jul; 2(7979):228-31. PubMed ID: 59243
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Letter: Immunodeficiency and epilepsy.
    Kanoh T; Uchino H
    Lancet; 1976 Apr; 1(7964):860-1. PubMed ID: 56677
    [No Abstract]   [Full Text] [Related]  

  • 23. Permanent intrinsic B cell immunodeficiency caused by phenytoin hypersensitivity.
    Guerra IC; Fawcett WA; Redmon AH; Lawrence EC; Rosenblatt HM; Shearer WT
    J Allergy Clin Immunol; 1986 Apr; 77(4):603-7. PubMed ID: 3082959
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of phenytoin and carbamazepine treatment on nonspecific immunological reactivity in epilepsy].
    Członkowska A; Niedzielska K; Korlak J
    Neurol Neurochir Pol; 1981; 15(3):297-302. PubMed ID: 7312107
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum IgA, IgG, and IgM concentrations in patients with epilepsy and matched controls: a cohort-based cross-sectional study.
    Ranua J; Luoma K; Auvinen A; Peltola J; Haapala AM; Raitanen J; Isojärvi J
    Epilepsy Behav; 2005 Mar; 6(2):191-5. PubMed ID: 15710303
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reversible total IgA deficiency associated with phenytoin treatment.
    Braconier JH
    Scand J Infect Dis; 1999; 31(5):515-6. PubMed ID: 10576137
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunoglobulins in epilepsy.
    Bassanini M; Baez A; Sotelo J
    J Neurol Sci; 1982 Nov; 56(2-3):275-81. PubMed ID: 7175551
    [No Abstract]   [Full Text] [Related]  

  • 28. Lymphocyte subpopulations and lymphocyte function in phenytoin-treated patients with epilepsy.
    Gilhus NE; Matre R; Aarli JA
    Int J Immunopharmacol; 1982; 4(1):43-8. PubMed ID: 6979523
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ineffectiveness of folic acid supplementation against phenytoin-induced decrease in salivary immunoglobulin A concentration of epileptic patients.
    Zare M; Ghazvini MR; Yazdi HR; Nezhad VS; Chitsaz A
    Eur Neurol; 2008; 59(6):299-301. PubMed ID: 18408370
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of phenytoin on immunoglobulins A, G and M].
    Jadot G; Valli M; Bussiere H; Bruguerolle B; Bouyard P
    Nouv Presse Med; 1982 Dec; 11(51):3796-7. PubMed ID: 7155886
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of phenytoin on man's immunity. Evaluation of changes in serum immunoglobulins, complement, and antinuclear antibody.
    Bardana EJ; Gabourel JD; Davies GH; Craig S
    Am J Med; 1983 Feb; 74(2):289-96. PubMed ID: 6600585
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phenytoin influence on human lymphocyte mitogen response: a prospective study of epileptic and nonepileptic patients.
    Gabourel JD; Davies GH; Bardana EJ; Ratzlaff NA
    Epilepsia; 1982 Aug; 23(4):367-76. PubMed ID: 7094904
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunoglobulin abnormalities in relatives of IgA deficient epileptics.
    Fontana A; Grob PJ; Sauter R
    J Neurol; 1978 Feb; 217(3):207-12. PubMed ID: 75956
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Suppression of IgA production by lymphocytes induced by diphenylhydantoin.
    Kondo N; Takao A; Tomatsu S; Shimozawa N; Suzuki Y; Ogawa T; Iwata H; Orii T
    J Investig Allergol Clin Immunol; 1994; 4(5):255-7. PubMed ID: 7874323
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduced CSF IgG in patients treated with phenytoin (diphenylhydantoin).
    Fossan GO
    Eur Neurol; 1976; 14(6):426-32. PubMed ID: 991879
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Transient lowering of the IgA level during Diphedan therapy].
    Balogh E; Máttyus A; Németh C; Szabadosné NM
    Orv Hetil; 1979 Sep; 120(36):2179-82. PubMed ID: 514604
    [No Abstract]   [Full Text] [Related]  

  • 37. Immunological abnormalities and HLA antigen frequencies in IgA deficient patients with epilepsy.
    Fontana A; Joller H; Skvaril F; Grob P
    J Neurol Neurosurg Psychiatry; 1978 Jul; 41(7):593-7. PubMed ID: 99491
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Respiratory disease and nasal immunoglobulin concentrations in phenytoin-treated epileptic patients.
    Gilhus NE; Aarli JA
    Acta Neurol Scand; 1981 Jan; 63(1):34-43. PubMed ID: 7468159
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunoglobulin deficiencies: the B-lymphocyte side of DiGeorge Syndrome.
    Patel K; Akhter J; Kobrynski L; Benjamin Gathmann MA; Davis O; Sullivan KE;
    J Pediatr; 2012 Nov; 161(5):950-3. PubMed ID: 22809661
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of diphenylhydantoin in serum and secretory IgA concentrations.
    Martínez-Cairo S; Guiscafre H; Alvarez MT; Muñóz-Hernández O
    Arch Invest Med (Mex); 1980; 11(1):1-8. PubMed ID: 6772121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.